Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ZGNX:US

1.4100 USD 0.1300 8.44%

As of 17:20:00 ET on 04/27/2015.

Company Profile for Zogenix Inc (ZGNX)

Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.

Contact Information

Zogenix Inc

12671 High Bluff Drive
Suite 200
San Diego, CA 92130
United States
Phone: 1-858-259-1165
Fax: 1-858-259-1166

Key Executives for Zogenix Inc (ZGNX)

Stephen J FarrCEO/Co-FounderAnn D RhoadsExec VP/CFO/Treasurer/Secy
Bradley Stuart Galer "Brad Gale"Exec VP/Chief Medical OfficerJohn J TuraninVP & General Mgr:Zogenix Tech
Bret E MegargelVP:Corporate Dev/Co-FounderStephen H JennerVP:Marketing
Edward F Smith IIIVP:Regulatory Affairs & DrugMark R ThompsonVP:Sales & Managed Markets
Jeff D DurflingerVP:Technical Ops & ProductArnold R GammaitoniVP:Medical & Scientific Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil